Compounds > pd 153035

pd 153035 and N-(3-ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine

pd 153035 has been researched along with N-(3-ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, PH; Carlo, AA; Hageman, DL; Mathiowetz, AM; McClure, LD; Treadway, JL; Withka, JM; Wright, SW1
Elmaghrabi, MR; Mubarak, MS; Tayyem, RF; Yousef, AM; Zalloum, HM1
Asquith, CRM; Drewry, DH; East, MP; Havener, TM; Johnson, GL; Laitinen, T; Morris, DC; Naegeli, KM; Wells, CI; Zuercher, WJ1
Asquith, CRM; Crona, DJ; Fleck, N; Grundner, C; Torrice, CD; Zuercher, WJ1

Other Studies

4 other study(ies) available for pd 153035 and N-(3-ethynylphenyl)-6,7-dimethoxy-4-quinazolinamine

ArticleYear
Allosteric inhibition of fructose-1,6-bisphosphatase by anilinoquinazolines.
    Bioorganic & medicinal chemistry letters, 2001, Jan-08, Volume: 11, Issue:1

    Topics: Allosteric Regulation; Allosteric Site; Aniline Compounds; Animals; Drug Design; Enzyme Inhibitors; Fructose-Bisphosphatase; Humans; Inhibitory Concentration 50; Kidney; Liver; Models, Molecular; Molecular Structure; Quinazolines; Structure-Activity Relationship

2001
Ligand-based designing, in silico screening, and biological evaluation of new potent fructose-1,6-bisphosphatase (FBPase) inhibitors.
    European journal of medicinal chemistry, 2012, Volume: 56

    Topics: Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Fructose-Bisphosphatase; High-Throughput Screening Assays; Humans; Ligands; Liver; Models, Molecular; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship

2012
Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma.
    Journal of medicinal chemistry, 2019, 05-09, Volume: 62, Issue:9

    Topics: Aminoquinolines; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chordoma; Drug Design; ErbB Receptors; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Molecular Docking Simulation; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines

2019
Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines.
    Bioorganic & medicinal chemistry letters, 2019, 09-15, Volume: 29, Issue:18

    Topics: Aniline Compounds; Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Quinolines; Structure-Activity Relationship

2019